Pharma Journalist 9038 posts 0 comments

Rallybio, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, announced the…
Read More...

Amplyx Pharmaceuticals announced that it has advanced development of its lead program, fosmanogepix (APX001). Enrollment has been completed in a Phase 2 trial evaluating the safety and…
Read More...

PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova…
Read More...

SMi Reports: The 2nd Annual Next Generation Pharmaceutical Cleanroom Conference will convene in London on 7th – 8th October 2020. Following on from the success of last years…
Read More...

AveXis, a Novartis company, announced the European Commission (EC) granted conditional approval for Zolgensma (onasemnogene abeparvovec) for the treatment of patients with 5q spinal…
Read More...

Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America's most essential…
Read More...

Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally inaccessible targets, today announced that it…
Read More...

Starts NEXT WEEK - May 25th-30th! Join 40+ great speakers from 25+ countries sharing timely insights and case studies about healthcare transformation and current digital healthcare…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced results from the Phase 1 CHRYSALIS study evaluating amivantamab (JNJ-6372) in the treatment of patients with…
Read More...